Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Helocyte, Inc. (“Helocyte”), a company founded by Fortress Biotech, Inc., is focused on the development and commercialization of novel immunotherapies for the prevention and treatment of cancer and infectious disease (in particular, cytomegalovirus or “CMV”).Developer of immunotherapies designed for the treatment and prevention of cancer and infectious disease. The company develops PepVax and Triplex vaccines for the t...
Helocyte, Inc. (“Helocyte”), a company founded by Fortress Biotech, Inc., is focused on the development and commercialization of novel immunotherapies for the prevention and treatment of cancer and infectious disease (in particular, cytomegalovirus or “CMV”).Developer of immunotherapies designed for the treatment and prevention of cancer and infectious disease. The company develops PepVax and Triplex vaccines for the treatment of cancer and infectious diseases like cytomegalovirus or CMV, enabling customers to lower the risk of cancer.

List your booth number for exhibitions, ask us